Delivery and Safety of a Two-Dose Preventive Ebola Virus Disease Vaccine in Pregnant and Non-Pregnant Participants during an Outbreak in the Democratic Republic of the Congo

During the 2018–2020 Ebola virus disease (EVD) outbreak, residents in Goma, Democratic Republic of the Congo, were offered a two-dose prophylactic EVD vaccine. This was the first study to evaluate the safety of this vaccine in pregnant women. Adults, including pregnant women, and children aged ≥1 ye...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccines Jg. 12; H. 8; S. 825
Hauptverfasser:	Kavunga-Membo, Hugo, Watson-Jones, Deborah, Kasonia, Kambale, Edwards, Tansy, Camacho, Anton, Mambula, Grace, Tetsa-Tata, Darius, Choi, Edward Man-Lik, Aboubacar, Soumah, Brindle, Hannah, Roberts, Chrissy, Manno, Daniela, Faguer, Benjamin, Mossoko, Zephyrin, Mukadi, Pierre, Kakule, Michel, Balingene, Benith, Mapendo, Esther Kaningu, Makarimi, Rockyath, Toure, Oumar, Campbell, Paul, Mousset, Mathilde, Nsaibirni, Robert, Ama, Ibrahim Seyni, Janvier, Kikongo Kambale, Keshinro, Babajide, Cissé, Badara, Sahani, Mateus Kambale, Johnson, John, Connor, Nicholas, Lees, Shelley, Imbault, Nathalie, Robinson, Cynthia, Grais, Rebecca F., Bausch, Daniel G., Muyembe-Tamfum, Jean Jacques
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Switzerland MDPI AG 23.07.2024 MDPI
Schlagworte:	Ad26.ZEBOV/MVA-BN-Filo Babies Birth weight Births Breastfeeding & lactation Case reports Cesarean section Children Clinical trials Consent DRC Ebola Ebola virus Ebolavirus Fatalities Hypothesis testing Immunization Low birth weight Medicine Menstruation Neonates outbreak Outbreaks Pregnancy Premature birth Public health R safety vaccine Vaccines Viral diseases Womens health Congo-Democratic Republic of Congo United States > US vaccine pregnant women DRC safety outbreak Ad26.ZEBOV/MVA-BN-Filo general population Ebola
ISSN:	2076-393X, 2076-393X
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!